MedTrace Logo

Exploring Hypertonia in Children With Cerebral Palsy

NCT01744158 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2012-12-06

No results posted yet for this study

Summary

Abnormal limb and trunk movements are seen in many children with cerebral palsy. Recognizing the difference between types of these movements is not well understood. This study aims to describe how common are these movements in children recruited from a population-based sample of children identified on a cerebral palsy register, and to explore associations with motor abilities. It is hoped this will lead to improved understanding and recognition of movement disorders in CP, to allow clinicians to choose appropriate treatments. We hypothesise that the underlying prevalence of dyskinesia is higher than that previously identified through conventional motor descriptions in cerebral palsy populations in Australia, and may approach 20%.

Conditions

  • Cerebral Palsy.

Interventions

OTHER

No intervention applicable

Following consent, children will undergo a comprehensive assessment performed by a research team including rehabilitation paediatrician and therapist. Hypertonia and abnormal movements will be assessed by a pediatrician with expertise in treating children with movement disorders. The assessments will be performed at a rehabilitation clinic, or child's home, and will include: * differentiation of hypertonia by application of the Hypertonia Assessment Tool-Discriminate (HAT-D) * measurement of severity of dystonia using the Barry Albright dystonia scale, based on video recording * measurement of severity of spasticity using the modified Ashworth score * description of presence of chorea or athetosis * classification of gross motor abilities using the GMFCS and functional mobility scale (FMS) * classification of fine motor abilities using the manual ability classification system (MACS) * collection of demographic data and associated medical history

Sponsors & Collaborators

  • Allergan Australia Pty Ltd

    collaborator INDUSTRY

  • Women's and Children's Hospital, Australia

    lead OTHER_GOV

Principal Investigators

  • James E Rice, MD · Women's and Children's Health Network

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-10-31
Completion
2014-01-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01744158 on ClinicalTrials.gov